Please provide your email address to receive an email when new articles are posted on . Use of INCS was not linked to COVID-19-related mortality in the general population nor among patients with COPD ...

Can you provide a reference on a study of growth and the HPA axis after the longest duration available of the use of intranasal corticosteroids? There are several recent articles on the effects of ...

Among children with obstructive sleep-disordered breathing, the proportion that achieved symptom resolution did not differ ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Treatment of seasonal allergic rhinitis in patients ≥6 years old and perennial allergic rhinitis in patients ≥12 years old. Omnaris is an alcohol-free, hypotonic suspension formulation of the ...

Investigators based at Monash Children's Hospital and Royal Children's Hospital Melbourne report that a once-daily intranasal ...

For severe chronic rhinosinusitis with nasal polyps, the novel monoclonal antibody stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid. The polyp size ...